When CLL Changes: A Guide for Patients
Richter transformation (RT) is a rare but serious change that can happen in people with chronic lymphocytic leukemia (CLL), where the slower-growing CLL becomes a more aggressive form of lymphoma.
Visit our CLL Information and Resource CentreA guide for patients looking for answers to their CLL questions on the Internet. |
Richter transformation (RT) is a rare but serious change that can happen in people with chronic lymphocytic leukemia (CLL), where the slower-growing CLL becomes a more aggressive form of lymphoma.
Combination treatments using drugs that target different CLL mechanisms have shown promising results for patients in clinical trials. And the great news is that some treatments that combine BTK and BCL2 inhibitors are now being approved as first line treatment options in Canada.
Understanding your preferred communication style can significantly enhance your relationship with your healthcare team and empower you to make informed decisions about your health.
The development of a new cancer drug at the University of Alberta shows both the promise and the challenges of drug development.
There is some good news to share on the treatment front! Since spring 2025, six provinces in Canada have made publicly funded Ibrutinib + Venetoclax (I+V) combination therapy available for previously untreated CLL patients.
Over a ten-year span, the treatment landscape for chronic lymphocytic leukemia (CLL) has improved dramatically.
As a CLL patient, taking an active role in your healthcare can be a game-changer – and doing your own research is a powerful way to start.
With a flare up of measles cases in Canada, how concerned do we need to be when we have an immune system weakened by CLL?
For CLL patients at any age, the idea of running out of treatment options is a big concern. This is especially true for those who are younger and/or raising a family.
Changes are afoot in CLL Canada’s online presence, with a new format for our bulletin, an updated website and French language pages.